chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Hello,   When I received my second Covid vaccine, I was asked to report my side effects to this email address.  They are as follows:   After Vaccine 1 (12/22/20):  I had the vaccine at around 1:30pm.  I only had arm-stiffness at first.  Approx. 24 hours after however (1:30pm the next day), I started having chills and feeling like I had a fever.  My entire body ached but I did not have a headache.  These side effects lasted through the night for approx. 14 hours.   The following day I woke up with a surge of energy and felt very much like I had been given a shot of adrenalin.  I?m not sure that I have ever felt as good.   After Vaccine 2 (01/11/21):  I had much more severe side effects after the second vaccine.  I had this vaccine at approx. 1:30 pm and within a couple of hours I started to feel a bit tired.  At approx. midnight that night, I started having body aches and a headache that woke me up.  I had chills and was oscillating between feeling very cold and feeling very hot.  Through the night I had to change my clothing several times due to sweating.  These symptoms lasted for the entire following day.  The second day after the vaccine I felt much better but still a little tired.    Of greatest concern is that I have a lingering pain deep within my left arm (the arm into which the shots were given).  Having a hard time extending my arm and doesn;t seems to be going away.  Sometimes it feels tingly and I sometimes have loss of grip and/or weakness in the entire arm.     Hope this helps you in compiling the side effects.  Thank you.
patient experienced numbness down left side of body about 20 minutes after injection. she said it went from top of head to toe, she had been walking around store. stated did not feel like swelling of tongue or throat but numbness in left side. given benadryl 50mg caps in case it was allergy related as a precaution, pt was monitored about an hour before she decided to leave without recommended medical attention (911/ER visit)
12/22/2020 rec'd SARS-CoV-2  Pfizer 1/12/2021 rec'd SARS-CoV-2   Pfizer 10/8/2021 rec'd SARS-CoV-2  Pfizer (booster)  At 11PM on 10/8/2021 I started feeling my right arm still and aching all over. Woke up at 7:30 AM on 10/9/2021 and looked in mirror and my arm was red and warm to touch.  It was a total of 6" across red.  By 8:30 AM I had swelling in my arm, my arm pit and into my right breast.  By 10:30 AM, I could tell there was swelling in my gland in my arm pit.  Fever of 101 and I took Motrin and Tylenol.   Swelling went past my elbow.   I kept it elevated and  contacted one of the Pediatric Endocrinologist (MD) that I work for and he suggested Motrin, Tylenol and if not better by October 11, to  go into the health office where I work.   As of today it is much better with some swelling in the arm pit but nothing like over the weekend.
1st dose, fever, headache. rash. Rash was painful that became red spots. after a couple of weeks the rash still is there. anxiety attacks.
MMR given on 2/22/02. Two weeks later, broke out in a rash. Developed bilateral hip pain and macular rash on anterior lower abdomen. Complained of bilateral hip, anterior groin and upper thigh discomfort. Full ROM. (-) Patrick test bilaterally. Treated with Advil and Benadryl at night for itching. Symptoms resolved after approx. 9 weeks.
Initially vaccine was stored in fridge on 07 Feb 2022and was administered on 20 APR 2022 after more than 30 days; Expired doses of Moderna COVID-19 were administered beyond the beyond use date.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired doses of Moderna COVID-19 were administered beyond the beyond use date.) and PRODUCT STORAGE ERROR (Initially vaccine was stored in fridge on 07 Feb 2022and was administered on 20 APR 2022 after more than 30 days) in a 53-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 083J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 20-Apr-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired doses of Moderna COVID-19 were administered beyond the beyond use date.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Initially vaccine was stored in fridge on 07 Feb 2022and was administered on 20 APR 2022 after more than 30 days). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired doses of Moderna COVID-19 were administered beyond the beyond use date.) and PRODUCT STORAGE ERROR (Initially vaccine was stored in fridge on 07 Feb 2022and was administered on 20 APR 2022 after more than 30 days) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were provided. It was reported that, the patient received total 3 doses and this was booster dose. Vial did not undergo any temperature excursions. No treatment medications were provided.   This case was linked to MOD-2022-584679, MOD-2022-584673 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Follow-up information was received includes patient demographics, event product storage error added and reporter details updated.
Upper LL swollen size of soft ball. Red ring, purple inside, red needle mark at injection site. Super sensitive. Shot received Thurs. 9/19. Did not appear until Saturday 9/21. Went to hospital. Was told use Benadryl and Tylenol. Went down Sunday night. Back to normal Monday.
Pt recv vax on 3/15/99; on same day pt exp screaming, fever (+100), shaking, irritable, dec appetite, red/swollen vax site (DTaP-lt leg)
severe headache; muscle aches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP), Program ID: The reporter is the patient.  A 51-year-old patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 18Apr2023 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunization; Bnt162b2 (DOSE 2, SINGLE), for COVID-19 immunization; Bnt162b2 (DOSE NUMBER UNKNOWN (BOOSTER), SINGLE), for COVID-19 immunization. The following information was reported: MYALGIA (non-serious) with onset 19Apr2023, outcome "unknown", described as "muscle aches"; HEADACHE (non-serious) with onset 19Apr2023, outcome "unknown", described as "severe headache".  Additional Information: Patient had not experienced anything with the previous Pfizer boosters. The headache was really bad. Patient never had COVID.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Client reported that 6 days after vaccine she developed a quarter size red mark on her arm that then developed to the size of a cupcake. Denies pain, just redness and itching.
Within 6 minutes left side of face, neck and head started getting numb. Had a rash on neck and chest.  Blood pressure went up.  Got really weak. Was necessary to go to hospital for meds and monitoring. This morning  March 6th, still weak with hurting joints.
This spontaneous report was received from medical assistant refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, drug reactions and allergies were not reported. The patient concomitant medication included sterile diluent (STERILE DILUENT). On an unknown date the patient was vaccinated with improperly stored dose of PROQUAD (dose, units and frequency not reported) (lot# N024562 and expiration date: 06-MAR-2019), subcutaneously at temperature excursion from -9 degree celsius (°C ) to 8 °C for 52 hours and 10 minutes and temperature excursion from  -l4°C to -10°C for 13 hours and 45 minutes. It was reported that there was no previous excursion. Digital data logger was involved. No adverse effects reported and no additional information was provided. No product quality complaint was involved.
Pt recv vax on 5/6/98; on 5/7/98 pt exp numbness down the LA;event is resolving.
Within 24 hour of vaccines administration a small area of redness and swelling appeared that progressively worsened. Area is red, hard and painful to touch. Appointment time afternoon.
tachycardia x 2 days. Dizziness x 2 days Aura only when >143 heartrate Appetite suppression x 2 days Extremely thirsty x 2 days Fatigue usually *starting to feel better but not all the way yet.
Admit date: 7/3/2023 2 Days Post-Op    Background: Patient is a 54 Y female admitted to the orthopedic service s/p removal of right lower extremity external fixator with ORIF right bicondylar tibial plateau fracture. Currently, with wound vac in place. Patient requiring supplemental oxygen. COIVD positive. Patient started on remdesivir and steroid.    Subjective: Patient denies any fevers, no chills, no headache, no abd pain, no constipation, no diarrhea, no urinary changes, no cough
Saturday, I had a runny nose, I thought it was allergies. I took a test at work it was negative. During the night I had night sweats, body ache and extreme back pain. I took a at home test it was positive. I called my doctor and was prescribed PAXLOVID and coughing pearls. The cough got worse and the congestion. I started getting short of breath and a headache. The back pain did not go away in my lower back. The cough is still going on and I am short of breath a lot of the time.
covid arm; hives on left side of face, neck and arms/patient had a hive that was massive that was purple and red in a big circle; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives on left side of face, neck and arms/patient had a hive that was massive that was purple and red in a big circle) and VACCINATION COMPLICATION (covid arm) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included AMLODIPINE and SIMVASTATIN for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced URTICARIA (hives on left side of face, neck and arms/patient had a hive that was massive that was purple and red in a big circle). On an unknown date, the patient experienced VACCINATION COMPLICATION (covid arm). On 01-Mar-2021, URTICARIA (hives on left side of face, neck and arms/patient had a hive that was massive that was purple and red in a big circle) had resolved. At the time of the report, VACCINATION COMPLICATION (covid arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication: The doctor prescribed Benadryl and hydrocortisone cream.
Patient exhibits redness and swelling on left arm at injection site, site feels warm and hard. Pt used ibuprofen and BENADRYL without symptom relief.
Tightness in left arm shoulder. Muscle between shoulder and neck constantly contracts, lifting shoulder up towards ear.
Information has been received from a registered nurse concerning a 21 year old female with no known drug allergies, who on 11/8/82 and 12/8/92 was vaccinated with a first and second dose of MMR II. On 8/9/02 the pt had a "titer" drawn which showed that she "failed to seroconvert to mumps and measles." Unspecified medical attention was sought. Additional info has been requested.
Patient was admitted for chief complaint of dyspnea, headache and fatigue. Patient was found to be positive for Covid-19 6 days prior to presentation and had monoclonal antibody therapy on 1/17. His symptoms persisted and he was found to be 88% on room air at home. He was treated with Decadron and supplemental O2. His respiratory status improved and he was able to be weaned back to room air.
p/vax that evening marked swelling, pain @ site reported;reported swollen fingers of rt hand w/tingling sensation, throbbing;saw MD 10/14/99 placed on ATB;
Fluarix vaccine given to client at approximately 0955 on 10/19/2020.  Fluarix quad LOT # 47G53, given IM in left deltoid.  Between 1200-1300, I was contact by a co-worker of client and was informed that clients tongue was swelling.  I instructed client should be taken to ED.   On 10/20/2020, I called and spoke with client.  He shared he was taken to  clinic to see his primary Dr.  He told me she gave him a shot of epinephrine and a 5 day Rx or some oral medications.  When I asked him if MD thought it was flu vaccine, client shared she never said.  Clients main concern was that the flu vaccine did not have the same component of Lisinopril.  As client has not tolerated that medication in the past.
Pt experienced an episode of syncope and fainting about 10-15 minutes after administration of his 2nd shingrix vaccine. The patient was instructed to wait for ~15  minutes and was sitting in a chair near the pharmacy consultation room with his wife. In the moment he was getting up to leave after waiting, he started to fall and a customer in line nearby was able to catch him before he fell. The man appeared to be unconscious and unresponsive. I ran out of the pharmacy to come to his aid and had my technician, call  911. After about 20 seconds of being unresponsive the man did 'wake up' and appeared to be alert and told me "I am okay, I am okay."  Medics arrived approximately 6 minutes later. We kept him sitting and upright during this time waiting for medics. The patient presented cold and clammy and i tried to assess his pulse with my finger tips: was normal about ~60 bpm. Medics came to the scene and took the man away in a stretcher. Will follow up with patient and wife today regarding his status.
pt recv vax 21OCT97 & approx 6hr p/vax pt devel swelling, erythema, warmth of the rt arm where the inj was given;ROM was intact;no signs of active infect;sx lasted 2 days & responded to symptomatic tx;
Patient reported feeling extremely lethargic and severe back pain that is affecting everyday activities. Back pain did not start until a few days after vaccination.
lightheaded, fatigue, tight jaw, head pressure. Evaluated by EMS-Cleared
Itchy nose, Swelling/redness to eye lids, Hives, Seen At PCP Office 11/18/2009. Given dose of solu-medrol.
Dizziness; loss of taste; Loss of appetite; Muscle aches; Headaches; Fever of 101.4; Shaking chills; This spontaneous case was reported by a physician and describes the occurrence of DIZZINESS (Dizziness), AGEUSIA (loss of taste), DECREASED APPETITE (Loss of appetite), MYALGIA (Muscle aches) and HEADACHE (Headaches) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Feb-2021, the patient experienced DIZZINESS (Dizziness), AGEUSIA (loss of taste), DECREASED APPETITE (Loss of appetite), MYALGIA (Muscle aches), HEADACHE (Headaches), PYREXIA (Fever of 101.4) and CHILLS (Shaking chills). The patient was treated with PARACETAMOL (TYLENOL) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, DIZZINESS (Dizziness), MYALGIA (Muscle aches), HEADACHE (Headaches) and CHILLS (Shaking chills) had resolved and AGEUSIA (loss of taste), DECREASED APPETITE (Loss of appetite) and PYREXIA (Fever of 101.4) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Feb-2021, Body temperature: 101.4 (Inconclusive) Fever of 101.4. On an unknown date, Body temperature: 98.6 (Inconclusive) temp at 98.6.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  Concomitant product use was not provided by the reporter.
Six hours after injection I started to have chills, fever, headache, nausea, joint pain and skin had a stinging sensation.  I could not sleep all night because of the pain in my joints and headache.  Next day I had low grade fever but chills had stopped. I was very tired and was unable to stay up sleeping much of the time.  Nausea persisted.  Next day I was a lot better and was able to do my regular routine altho was tired.  I did not get any medical attention. I thought It would disappear by itself which it did.
COVID 19 Treatment/ I tested positive on Saturday 11Jun; COVID 19 Treatment/ I tested positive on Saturday 11Jun; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 29-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 05Dec2021 as dose 3 (booster), single (Lot number: 330308D) at the age of 27 years for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 23Mar2021 as dose 1, single (Lot number: 046A21A), in left arm and on 20Apr2021 as dose 2, single (Lot number: 001C21A), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Moderate/severe asthma" (unspecified if ongoing); "allergies to dust" (unspecified if ongoing); "pollen" (unspecified if ongoing); "mold" (unspecified if ongoing); "pet dander" (unspecified if ongoing). Concomitant medication(s) included: SYMBICORT; SINGULAIR; CETIRIZINE. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment/ I tested positive on Saturday 11Jun". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (11Jun2022) Positive, notes: I tested positive; (21Jun2022) Positive, notes: Tuesday June 21 I tested positive for COVID. Therapeutic measures were taken as a result of drug ineffective, covid-19.; Sender's Comments: Based on the information provided in the narrative, a causal association between the suspect drug and the events cannot be completely excluded.
Small white bump at injection site, redness expanding 3 inches in a rectangular pattern, hot to touch and tender.
Felt chills, started shivering/shaking, temperature rose to 100 in 30 minutes. Went to 102 through the night even with aspirin at appropriate intervals. Next morning light headedness and low grade fever and nausea and a partial loss of taste and appetite. Continued into 48 hours. Third day nausea, loss of taste, appetite. Fourth day loss of appetite, nausea. Normal again day five.
On Jan 28th at approximately 4 am I woke up with severe body aches, a fever of 101.2, severe fatigue, chest pains, headache, nausea,  chills. I have slept the entire day, unable to get up. And of course the arm where the injection was administered feels like lead.
T-dap 12/2/19 IM (L) deltoid 12/2/2019 noon. Pt developed temp 100.2 PO with shaking/chills, aches, pains, fatigue Temp 12/3/19 99.3. PO. Pt sent to Hospital for evaluation. 30wk pregnant with twins. Pt afebrile in 48 hr from 12/2/2019 episode.
dizzy; vertigo; on a tilt a whirl; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), VERTIGO (vertigo) and VERTIGO (on a tilt a whirl) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007821A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced DIZZINESS (dizzy), VERTIGO (vertigo) and VERTIGO (on a tilt a whirl). At the time of the report, DIZZINESS (dizzy), VERTIGO (vertigo) and VERTIGO (on a tilt a whirl) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment medications was not provided.
12 hours post vax infant received shots she had a febrile seizure was taken to ER.
Vaccination dates were 05 March 2021 and 26 March 2021.  On 05 April, patient was taken to ED with neurological symptoms and was put on stroke protocol.  MRI on 06 April confirmed CVA.  Patient was currently taking atenolol for long-standing mild heart arrhythmia.  BP was elevated upon check in.  On 07 April patient was discharged continuing low dose aspirin and Plavix as well as atenolol and suggested to follow up with a neurologist and her cardiologist.  Upon discharge patient did not seem to have any ongoing neurological deficits.
Information has been received from a physician concerning a 15 year old male who on 22-APR-1999 was vaccinated with a first dose of MMR II.  On 15-DEC-1999 the patient was vaccinated with a second dose of MMR II. On 11-NOV-2009 the patient experienced mumps (thought the date diagnosed was reported as 03-DEC-2009).  On 03-DEC-2009 the patient had the following laboratories tests done: serum immunoglobulin M test (<1:10), serum immunoglobulin G test (7.22) and a serum amylase test (67).  The patient was afebrile and had parotitis.  The patient's outcome was unknown.  Follow up information has been received and indicated that the 15 year old patient (also reported as 14 year old) experienced mumps on 17-NOV-2009 (previously reported as 11-NOV-2009) and was diagnosed on 19-NOV-2009.  The patient was reported as afebrile, had (both sides) parotitis and headache for 2 days.  Diagnostic laboratory tests performed on 19-NOV-2009 included IgM: <1:10 and IgG: 3.88.  This one of several reports received from the same source.  No further information is available.
Received 1st shot 31 Mar, 2nd on 14 Apr, on 15 Apr woke up wide awake about 0300 hrs, unable to sleep, slept about 4 hrs the night of the 16th, very jittery, felt like he "took 10 Sudafed", dizzy, off balance, cold symptoms, increased BP on 23 Apr.
Screaming for 20 minutes "hi pitched", burped then better (about 36 hours after vaccines). T 100.8 R 1 hour after acet. but unsure how much of dose spit out.
All covid vaccinations caused pain with Humira; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (All covid vaccinations caused pain with Humira) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced PAIN (All covid vaccinations caused pain with Humira). At the time of the report, PAIN (All covid vaccinations caused pain with Humira) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant and treatment medication was not reported.   This case was linked to MOD-2022-588180, MOD-2022-588246 (Patient Link).